Evidence map›Paper›PMID 33852141›Full record

ArticleJournal of general internal medicine2021

The Utilization and Costs of Grade D USPSTF Services in Medicare, 2007-2016.

Carlos Irwin A Oronce, A Mark Fendrick, Joseph A Ladapo, Catherine Sarkisian, John N Mafi

Open access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Carlos Irwin A OronceVA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
A Mark FendrickDepartment of Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Joseph A LadapoDivision of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Catherine SarkisianDivision of Geriatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
John N MafiDivision of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. jmafi@mednet.ucla.edu.ORCID 0000-0002-0322-7636
University of California, Los Angeles · USRAND Corporation · USUniversity of Michigan · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
The Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Homero Erwin del Pino · 2002 to 2026
$19.7M
The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
U.S. Deprescribing Research NetworkR24AG064025 · NIA · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BOYD, CYNTHIA MELINDA, STEINMAN, MICHAEL A. · 2019 to 2023
$9.9M
Financial incentive strategies for smoking cessation in high-risk, hospitalized patients.R01DA045688 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LADAPO, JOSEPH ABIODUN, SHERMAN, SCOTT E · 2019 to 2023
$3.8M
Financial incentive strategies for weight loss in obese patients living in socioeconomically disadvantaged neighborhoodsR01MD011544 · NIMHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JAY, MELANIE, WALI, SOMA · 2016 to 2020
$3.5M
Behavioral Economics and Implementation Research to Reduce Cardiovascular Risk in HIV-infected AdultsU01HL142104 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DIAMANT, ALLISON LESLIE · 2018 to 2021
$2.7M
Identifying Approaches to Measure and Reduce Harmful, Low-Value Care Among Older Americans with Mild Cognitive Impairment and DementiaR01AG070017 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAFI, JOHN N. · 2021 to 2025
$2.6M
Midcareer Award in Patient-Oriented Community-Academic Partnered Aging ResearchK24AG047899 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SARKISIAN, CATHERINE A · 2014 to 2025
$2.0M
Pragmatic Trial of an Electronic Health Record/Behavioral Economics Intervention to Reduce Pre-operative Testing for Cataract SurgeryR01AG059815 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SARKISIAN, CATHERINE A · 2018 to 2021
$2.0M
Leveraging Electronic Health Records to Measure and Reduce Harmful, Low-Value Care Among Older AdultsK76AG064392 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAFI, JOHN · 2020 to 2024
$1.2M
NCATS NIH HHS KL2 TR001882NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1TR001881NHLBI NIH HHS U01 HL142104NIA NIH HHS 1K24AG047899NIA NIH HHS 1K76AG064392-01A1NIA NIH HHS K24 AG047899NIA NIH HHS K76 AG064392NIA NIH HHS P30 AG021684NIA NIH HHS R01 AG059815NIA NIH HHS R01AG059815-01NIA NIH HHS R01 AG070017NIA NIH HHS R24 AG064025NIDA NIH HHS R01 DA045688NIH HHS KL2TR001882NIH HHS P30-AG021684NIMHD NIH HHS R01 MD011544
6 · The paper itself

Abstract

backgroundLow-value care, or patient care that offers no net benefit in specific clinical scenarios, is costly and often associated with patient harm. The US Preventive Services Task Force (USPSTF) Grade D recommendations represent one of the most scientifically sound and frequently delivered groups of low-value services, but a more contemporary measurement of the utilization and spending for Grade D services beyond the small number of previously studied measures is needed.

objectiveTo estimate utilization and costs of seven USPSTF Grade D services among US Medicare beneficiaries.

designWe conducted a cross-sectional study of data from the National Ambulatory Medical Care Survey (NAMCS) from 2007 to 2016 to identify instances of Grade D services. SETTING/

participantsNAMCS is a nationally representative survey of US ambulatory visits at non-federal and non-hospital-based offices that uses a multistage probability sampling design. We included all visits by Medicare enrollees, which included traditional fee-for-service, Medicare Advantage, supplemental coverage, and dual-eligible Medicare-Medicaid enrollees. MAIN MEASURES: We measured annual utilization of seven Grade D services among adult Medicare patients, using inclusion and exclusion criteria from prior studies and the USPSTF recommendations. We calculated annual costs by multiplying annual utilization counts by mean per-unit costs of services using publicly available sources. KEY

resultsDuring the study period, we identified 95,121 unweighted Medicare patient visits, representing approximately 2.4 billion visits. Each year, these seven Grade D services were utilized 31.1 million times for Medicare beneficiaries and cost $477,891,886. Three services-screening for asymptomatic bacteriuria, vitamin D supplements for fracture prevention, and colorectal cancer screening for adults over 85 years-comprised $322,382,772, or two-thirds of the annual costs of the Grade D services measured in this study.

conclusionsUS Medicare beneficiaries frequently received a group of rigorously defined and costly low-value preventive services. Spending on low-value preventive care concentrated among a small subset of measures, representing important opportunities to safely lower US health care spending while improving the quality of care.

Indexed as

Low-Value CareMedicareAgedCross-Sectional StudiesFee-for-Service PlansHumansPreventive Health ServicesUnited Stateslow-value careMedicarequalityUSPSTFvalue

Identifiers

PMID33852141
PMCPMC8045442
OpenAlexW3153194268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.